Valuation Pharmaron Beijing Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-09			5-day change	1st Jan Change
31.59 ^CNY	+1.31%		+11.12%	+11.12%

Dec. 18	Pharmaron Beijing Co., Ltd. Announces Election of Mr. Li Shing Chung Gilbert as Employee Representative Director Effective December 18, 2025	CI
25-10-28	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	94,292	106,395	76,952	47,371	41,846	52,642	52,642	-
Change	-	12.84%	-27.67%	-38.44%	-11.66%	25.8%	0%	-
Enterprise Value (EV) ¹	92,214	107,852	80,810	51,092	46,049	54,958	54,112	52,520
Change	-	16.96%	-25.07%	-36.78%	-9.87%	19.35%	-1.54%	-2.94%
P/E ratio	81.5x	68.8x	58.6x	32.1x	25.4x	32.2x	26.3x	21.9x
PBR	10.8x	11.1x	7.83x	4.12x	3.35x	3.7x	3.2x	2.8x
PEG	-	1.8x	-3.9x	1.9x	2.1x	-10.06x	1.2x	1.1x
Capitalization / Revenue	18.4x	14.3x	7.5x	4.11x	3.41x	3.74x	3.28x	2.86x
EV / Revenue	18x	14.5x	7.87x	4.43x	3.75x	3.9x	3.37x	2.85x
EV / EBITDA	54.5x	45x	34.8x	18.7x	14.6x	16.1x	13.5x	11.2x
EV / EBIT	69.7x	56.3x	47.8x	29.7x	21.9x	25.3x	20.2x	16.4x
EV / FCF	274x	-3,252x	-101x	-540x	85.4x	33.9x	31.9x	24.8x
FCF Yield	0.36%	-0.03%	-0.99%	-0.19%	1.17%	2.95%	3.14%	4.03%
Dividend per Share ²	0.1333	0.2	0.2	0.2	0.2	0.2062	0.253	0.2977
Rate of return	0.25%	0.32%	0.44%	0.69%	0.78%	0.65%	0.8%	0.94%
EPS ²	0.6569	0.9128	0.7739	0.9019	1.011	0.9789	1.199	1.438
Distribution rate	20.3%	21.9%	25.8%	22.2%	19.8%	21.1%	21.1%	20.7%
Net sales ¹	5,134	7,444	10,266	11,538	12,276	14,075	16,056	18,432
EBITDA ¹	1,692	2,399	2,321	2,730	3,153	3,416	4,022	4,679
EBIT ¹	1,324	1,914	1,690	1,722	2,104	2,173	2,679	3,212
Net income ¹	1,172	1,661	1,375	1,601	1,793	1,721	2,178	2,631
Net Debt ¹	-2,077	1,457	3,859	3,721	4,203	2,316	1,470	-122.3
Reference price ²	53.51	62.79	45.33	28.98	25.70	31.55	31.55	31.55
Nbr of stocks (in thousands)	1,787,372	1,786,898	1,786,601	1,786,732	1,771,065	1,770,932	1,770,932	-
Announcement Date	3/28/21	3/10/22	3/30/23	3/27/24	3/26/25	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHARMARON BEIJING CO., LTD.	32.27x	3.91x	16.12x	0.65%	7.56B
LONZA GROUP AG	38.49x	5.59x	18.76x	0.89%	48.5B
IQVIA HOLDINGS INC.	34.13x	3.38x	14.56x	-.--%	41.28B
BEONE MEDICINES AG	103.38x	6.62x	66.63x	-.--%	37.39B
CELLTRION, INC.	57.29x	11.74x	32.63x	0.34%	32.52B
REVOLUTION MEDICINES, INC.	-21.24x	6162.36x	-20.13x	-.--%	22.94B
MEDPACE HOLDINGS, INC.	40.2x	6.51x	29.6x	-.--%	16.76B
EUROFINS SCIENTIFIC SE	27.01x	2.18x	9.76x	0.9%	14.24B
ICON PUBLIC LIMITED COMPANY	26.92x	2.09x	10.68x	-.--%	13.85B
Average	37.61x	689.38x	19.85x	0.31%	26.12B
Weighted average by Cap.	43.36x	606.60x	23.43x	0.31%